Literature DB >> 16175936

Seronegative systemic lupus erythematosus: etiology of nephrotic syndrome and acute renal failure in early postpartum period.

F N Ozdemir1, R Elsurer, A Akcay, B H Ozdemir, S Sezer, E Kuscu, M Haberal.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune syndrome that occurs most commonly in women during their reproductive years. Nephritis is known to be one of the most serious complications of SLE. Lupus nephropathy is frequently associated with ANA and anti-dsDNA antibodies. Rarely, serological markers may be initially absent, and in many cases, they become positive after sometime. We present a 28-year old, otherwise healthy female who admitted to our clinic with edema, hypertension, proteinuria and acute renal failure following her fourth delivery. Serum immunological markers were negative and renal biopsy showed histopathological changes consistent with systemic lupus erythematosus as the etiology of nephrotic syndrome. A dramatic therapeutic response was achieved by pulse steroid and cyclophosphamide treatment following oral steroid therapy. In women with new onset nephrotic syndrome or renal function deterioration in postpartum period, even if the patient is asymptomatic or seronegative, it is crucial to exclude SLE for a rapid diagnosis and prompt treatment in the case of lupus nephritis. Renal biopsy is of diagnostic importance in such cases in which there is no other clinical, biochemical and serological evidence of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16175936     DOI: 10.1191/0961203305lu2148cr

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  3 in total

Review 1.  Exploring the etiopathogenesis of systemic lupus erythematosus: a genetic perspective.

Authors:  Ali Javinani; Amir Ashraf-Ganjouei; Saeed Aslani; Ahmadreza Jamshidi; Mahdi Mahmoudi
Journal:  Immunogenetics       Date:  2019-01-22       Impact factor: 2.846

2.  Spontaneous autoimmunity in mice that carry an IghV partial transgene: a required arginine in VHCDR3.

Authors:  A Guth; T Detanico; D Smith; K S K Tung; C Bonorino; L J Wysocki
Journal:  Lupus       Date:  2009-04       Impact factor: 2.911

3.  An antinuclear antibody-negative patient with lupus nephritis.

Authors:  Hyoun Ah Kim; Jae Wook Chung; Han Jung Park; Dai Yeol Joe; Hyun Ee Yim; Hae Sim Park; Chang Hee Suh
Journal:  Korean J Intern Med       Date:  2009-03       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.